OncoMatch/Clinical Trials/NCT04910802
Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden
Is NCT04910802 recruiting? Yes, currently enrolling (May 2026). This Phase 4 trial studies Gardasil9 for hpv infection.
Treatment: Gardasil9 — The study aims to evaluate whether organised, concomitant HPV vaccination and HPV screening offered to all resident women aged 22-27 will result in a more rapid elimination of HPV infection in Sweden. This objective will be examined at the population level.
Check if I qualifyExtracted eligibility criteria
Cancer type
Cervical Cancer
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify